IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma

Ruidi Jiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hong Ge(Nanfang Hospital), Xiaoli Zheng(Zhengzhou University), Shuai Song(Shanghai Medical College of Fudan University), Zhuo Feng(China Pharmaceutical University), Yanan Sun(Zhengzhou University)
Frontiers in Oncology
July 7, 2020
10.3389/fonc.2020.01099
Cited by 21

Related Papers

Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment
|Biomaterials|2021|151
Long non-coding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93/ATG12 axis in colorectal cancer
|Cell Death and Disease|2020|109
Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC)
|Oncotarget|2017|46
<p>Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities</p>
|OncoTargets and Therapy|2019|39
Lipid metabolism analysis in esophageal cancer and associated drug discovery
|Journal of Pharmaceutical Analysis|2023|20